The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026 The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026
Vista Pharmaceuticals Ltd. Press Release Feb 05 2026
Filed with BSE ·
6ix hasn’t read this filing yet.
Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.2. Limited Review Report Quarter And Nine Months 31.12.2025.3. Any Other Business With The Permission Of The Chair.
- Vista Pharmaceuticals Ltd. Press Release Feb 03 2026
- Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 'Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd'
- Vista Pharmaceuticals Ltd. Press Release Jan 13 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Vista Pharmaceuticals
- Results For The Quarter Ended 31.12.2025
- Board Meeting Outcome for Un Audited Financial Results For The Quarter Ended 31.12.2025
- Vista Pharmaceuticals Ltd. Press Release Feb 13 2026
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Mar 27 2026
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals